PAMP
DFTX

Polar Asset Management Partners’s Definium Therapeutics DFTX Stock Holding History

Polar Asset Management Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,300
Closed -$190K – 761
2025
Q2 		$190K Buy
+29,300
New +$193K ﹤0.01% 442

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Polar Asset Management Partners's DFTX Position: Q3 2025 in Review

Polar Asset Management Partners sold out of Definium Therapeutics (DFTX) in Q3 2025, closing a stake of 29,300 shares — an estimated $190K sold.

Polar Asset Management Partners first reported a position in DFTX in Q2 2025 and held it in 1 quarter. The position peaked at $190K in Q2 2025. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • Polar Asset Management Partners reported no remaining Definium Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 29,300 Definium Therapeutics shares in Q3 2025, an estimated $190K.
  • Polar Asset Management Partners first reported a position in Definium Therapeutics in Q2 2025 and held it in 1 quarter.
  • Polar Asset Management Partners's Definium Therapeutics position peaked at $190K in Q2 2025.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.